Nauck M - Search Results

1

Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.

März W, Hoffmann MM, Scharnagl H, Fisher E, Chen M, Nauck M, Feussner G, Wieland H. März W, et al. Among authors: nauck m. J Lipid Res. 1998 Mar;39(3):658-69. J Lipid Res. 1998. PMID: 9548597 Free article.

2

Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated.

Nauck M, März W, Haas B, Wieland H. Nauck M, et al. Clin Chem. 1996 Mar;42(3):424-9. Clin Chem. 1996. PMID: 8598107

3

VLDL and LDL metabolism in human and rat mesangial cells.

Krämer-Guth A, Nauck M, Quaschning T, Pavenstädt H, Wieland H, Schollmeyer P, Wanner C. Krämer-Guth A, et al. Among authors: nauck m. Nephron. 1996;74(2):378-85. doi: 10.1159/000189339. Nephron. 1996. PMID: 8893159

4

Simple precipitation-based method for the screening of type III hyperlipoproteinemia.

Nauck M, Glatt L, März W, Feussner G, Wieland H. Nauck M, et al. Clin Chem. 1999 Jun;45(6 Pt 1):909-11. Clin Chem. 1999. PMID: 10352005 No abstract available.

5

Rapid, homogeneous genotyping of the 4G/5G polymorphism in the promoter region of the PAII gene by fluorescence resonance energy transfer and probe melting curves.

Nauck M, Wieland H, März W. Nauck M, et al. Clin Chem. 1999 Aug;45(8 Pt 1):1141-7. Clin Chem. 1999. PMID: 10430777

6

Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements.

Gierens H, Nauck M, Roth M, Schinker R, Schürmann C, Scharnagl H, Neuhaus G, Wieland H, März W. Gierens H, et al. Among authors: nauck m. Arterioscler Thromb Vasc Biol. 2000 Jul;20(7):1777-83. doi: 10.1161/01.atv.20.7.1777. Arterioscler Thromb Vasc Biol. 2000. PMID: 10894816

7

Evaluation of the Roche diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit.

Nauck M, März W, Wieland H. Nauck M, et al. Clin Biochem. 2000 Apr;33(3):213-6. doi: 10.1016/s0009-9120(00)00056-4. Clin Biochem. 2000. PMID: 10913521 No abstract available.

8

Evaluation of the Roche Diagnostics LightCycler-Apo B 3500 Mutation Detection Kit.

Nauck M, Wieland H, März W. Nauck M, et al. Clin Chem Lab Med. 2000 Jul;38(7):667-71. doi: 10.1515/CCLM.2000.096. Clin Chem Lab Med. 2000. PMID: 11028773

9

The Friedewald formula underestimates LDL cholesterol at low concentrations.

Scharnagl H, Nauck M, Wieland H, März W. Scharnagl H, et al. Among authors: nauck m. Clin Chem Lab Med. 2001 May;39(5):426-31. doi: 10.1515/CCLM.2001.068. Clin Chem Lab Med. 2001. PMID: 11434393 Clinical Trial.

10

Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells.

Scharnagl H, Schinker R, Gierens H, Nauck M, Wieland H, März W. Scharnagl H, et al. Among authors: nauck m. Biochem Pharmacol. 2001 Dec 1;62(11):1545-55. doi: 10.1016/s0006-2952(01)00790-0. Biochem Pharmacol. 2001. PMID: 11728391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,096 results

Search Page

Filters